awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q30053056-B1A4C884-0365-48C6-8294-2B330124A2A4
Q30053056-B1A4C884-0365-48C6-8294-2B330124A2A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30053056-B1A4C884-0365-48C6-8294-2B330124A2A4
Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
P433
Q30053056-B1A4C884-0365-48C6-8294-2B330124A2A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30053056-B1A4C884-0365-48C6-8294-2B330124A2A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fcbb97d9256718735d467b7b7803e9c483abde6f
P433
9856
http://www.w3.org/2001/XMLSchema#string